Download
- - Durgesh Ranjan Kar, Subhadip Bera, Abhipsa Sinha, et al./The job of Nutraceuticals in the avoidance of Cardiovascular disease/J Pharmaceut Med Chem. 2023;9(2): 65-72.

Download
- Durgesh Ranjan Kar, Subhadip Bera, Abhipsa Sinha, et al./The job of Nutraceuticals in the avoidance of Cardiovascular disease/J Pharmaceut Med Chem. 2023;9(2): 65-72.

Full Text (PDF)

Review Article

The Job of Nutraceuticals in the Avoidance of Cardiovascular Disease

Durgesh Ranjan Kar , Subhadip Bera , Abhipsa Sinha , Anshuman Bhattacharya

Author Information

Authors and Affiliatione

Durgesh Ranjan Kar
Professor, Department of Pharmacology, BCDA College of Pharmacy & Technology, Campus-2 Udairajpur, Madhyamgram, Kolkata 700129, West Bengal, India
Subhadip Bera
Assistant Professor, Department of Pharmacognosy, BCDA College of Pharmacy & Technology, Campus-2 Udairajpur, Madhyamgram, Kolkata 700129, West Bengal, India
Abhipsa Sinha
Assistant Professor, Department of Pharmacology, BCDA College of Pharmacy & Technology, Campus-2 Udairajpur, Madhyamgram, Kolkata 700129, West Bengal, India
Anshuman Bhattacharya
Assistant Professor, Department of Pharmaceutical Chemistry, BCDA College of Pharmacy & Technology, Campus-2 Udairajpur, Madhyamgram, Kolkata 700129, West Bengal, India

Address for correspondence: Durgesh Ranjan Kar, Professor, Department of Pharmacology, BCDA College of Pharmacy & Technology, Campus-2 Udairajpur, Madhyamgram, Kolkata 700129, West Bengal, India E-mail: durgesh176@gmail.com

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Journal of Pharmaceutical and Medicinal Chemistry 9(2):p 65-72, July - December 2023. | DOI: https://doi.org/10.21088/jpmc.2395.6615.9223.3

How Cite This Article:

Durgesh Ranjan Kar, Subhadip Bera, Abhipsa Sinha, et al./The job of Nutraceuticals in the avoidance of Cardiovascular disease/J Pharmaceut Med Chem. 2023;9(2): 65-72.

Timeline

Received : September 13, 2023 Accepted : October 30, 2023 Published : December 25, 2023

Abstract

One of the most well known health related and financial issues in the world is cardiovascular disease (CVD). Dietary factors affect other cardiovascular risk factors like hypertension, dyslipidemia, and diabetes mellitus, which can either directly or indirectly increase cardiovascular risk. Common dietary supplements known as Nutraceuticals have been proven to be successful in the treatment or prevention of disease. There is evidence that certain food groups and dietary supplements can slow the progression of CVD. This audit's goal is to report on the most recent research on the use of Nutraceuticals in the treatment and prevention of cardiovascular disease (CVD).

References

1. Stephen DF. The nutraceutical revolution, its impact on food industry. Trends in Food Sci. and Tech. 1995;6:59-61.
2. Voelter-Mahlknecht S. Epigenetic associations in relation to cardiovascular prevention and therapeutics. Clinical epigenetics. 2016 Dec;8(1):1-7.
3. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I. Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice.
4. O'Keeffe C, Kabir Z, O'Flaherty M, Walton J, Capewell S, Perry IJ. Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland. BMJ open. 2013 Jul 1;3(7):e002837.
5. Alissa EM, Ferns GA. Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. Journal of nutrition and metabolism. 2012 Jan 1;2012.
6. Tresserra-Rimbau A, Rimm EB. Medina-Rem on A, Mart ınez-Gonzalez MA, de la Torre R, Corella D, et al. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr Metab Cardiovasc Dis. 2014;24:639-47.
7. Lawson LD. Garlic: a review of its medicinal effects and indicated active compounds. Blood. 1998 Apr 15;179:62.
8. Lawson LD. The composition and chemistry of garlic cloves and processed garlic. Garlic: The science and therapeutic applications of Allium sativum L. and related species. 1996:37-109.9.
9. Ariga T, Seki T. Antithrombotic and anticancer effects of garlic derived sulfur compounds: A review. Biofactors. 2006;26(2):93-103. 10.
10. Bradley JM, Organ CL, Lefer DJ. Garlic-derived organic polysulfides and myocardial protection. The Journal of nutrition. 2016 Feb 1;146(2):403S-9S. 11.
11. Ariga T, Oshiba S, Tamada T. Platelet aggregation inhibitor in garlic. The Lancet. 1981 Jan 17;317(8212):150-112.
12. Apitz-C stro R, Cabrera S, Cruz MR, Ledezma E, Jain MK. Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure. Thrombosis research. 1983 Oct 15;32(2):155-69.
13. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, Darley-Usmar VM, Doeller JE, Kraus DW. Hydrogen sulfide mediates the vasoactivity of garlic. Proceedings of the National Academy of Sciences. 2007 Nov 13;104(46):17977-82.
14. Atkin M, Laight D, Cummings MH. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial. Journal of Diabetes and its Complications. 2016 May 1;30(4):723-7.
15. Qidwai W, Ashfaq T. Role of garlic usage in cardiovascular disease prevention: an evidencebased approach. Evidence-Based Complementary and Alternative Medicine. 2013 Oct;2013.
16. Donnarumma E, Trivedi RK, Lefer DJ. Protective actions of H2S in acute myocardial infarction and heart failure. Comprehensive Physiology. 2011 Jan 17;7(2):583-602.
17. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C. Anti-apoptotic and antiinflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock. 2009 Mar 1;31(3):267-74.
18. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutrition journal. 2002 Dec;1(1):1-4.
19. Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. The Journal of nutrition. 2006 Mar 1;136(3):736S-40S.
20. Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC cardiovascular disorders. 2008 Dec;8(1):1-2.
21. Ried K, Fakler P. Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance. Integrated blood pressure control. 2014;7:71.
22. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. Journal of hypertension. 1994 Apr 1;12(4):463-8.
23. Edwards QT, Colquist S, Maradiegue A. What's cooking with garlic: is this complementary and alternative medicine for hypertension?. Journal of the American Academy of Nurse Practitioners. 2005 Sep;17(9):381-5.
24. Turner B, Mølgaard C, Marckmann P. Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normolipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. British journal of nutrition. 2004 Oct;92(4):701-6.
25. Pittler MH, Ernst E. Clinical effectiveness of garlic (Allium sativum). Molecular nutrition & food research. 2007 Nov;51(11):1382-5.
26. Hoshino T, Kashimoto N, Kasuga S. Effects of garlic preparations on the gastrointestinal mucosa. The Journal of nutrition. 2001 Mar;131(3):1109S-13S.
27. RM CB. Functional properties and health benefits of lycopene. Nutricionhospitalaria. 2013 Jan 1;28(1):6- 15.
28. Burton-Freeman BM, Sesso HD. Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. Advances in Nutrition. 2014 Sep;5(5):457-85.
29. Hsu YM, Lai CH, Chang CY, Fan CT, Chen CT, Wu CH. Characterizing the lipidlowering effects and antioxidant mechanisms of tomato paste. Bioscience, biotechnology, and biochemistry. 2008 Mar 23;72(3):677-85.
30. Raiola A, Rigano MM, Calafiore R, Frusciante L, Barone A. Enhancing the healthpromoting effects of tomato fruit for biofortified food. Mediators of inflammation. 2014 Oct;2014.
31. Jacques PF, Lyass A, Massaro JM, Vasan RS, D'Agostino Sr RB. Relationship of lycopene intake and consumption of tomato products to incident CVD. British Journal of Nutrition. 2013 Aug;110(3):545-51.
32. Wolak T, Paran E. Can carotenoids attenuate vascular aging?. Vascular pharmacology. 2013 Sep 1;59(3-4):63-6.
33. Riccioni G, D'Orazio N, Palumbo N, Bucciarelli V, di Ilio E, Bazzano LA, Bucciarelli T. Relationship between plasma antioxidant concentrations and carotid intima-media thickness: the Asymptomatic Carotid Atherosclerotic Disease In Manfredonia Study. European Journal of Preventive Cardiology. 2009 Jun 1;16(3):351-7.
34. Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. Cmaj. 2000 Sep 19;163(6):739-44.
35. Pereira BL, Arruda FC, Reis PP, Felix TF, Santos PP, Rafacho BP, Gonçalves AF, Claro RT, Azevedo PS, Polegato BF, Okoshi K. Tomato (Lycopersiconesculentum) supplementation induces changes in cardiac miRNA expression, reduces oxidative stress and left ventricular mass, and improves diastolic function. Nutrients. 2015 Nov;7(11):9640-9.
36. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arteriosclerosis, thrombosis, and vascular biology. 2003 Feb 1;23(2):168-75.
37. Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. Journal of the American College of Cardiology. 2003 Oct 1;42(7):1149- 60.
38. Kim JY, Paik JK, Kim OY, Park HW, Lee JH, Jang Y, Lee JH. Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis. 2011 Mar 1;215(1):189-95.
39. Willcox JK, Catignani GL, Lazarus S. Tomatoes and cardiovascular health.
40. Chen J, Song Y, Zhang L. Effect of lycopene supplementation on oxidative stress: an exploratory systematic review and meta-analysis of randomized controlled trials. Journal of medicinal food. 2013 May 1;16(5):361-74.
41. Khan Z, Bhadouria P, Bisen PS. Nutritional and therapeutic potential of Spirulina. Current pharmaceutical biotechnology. 2005 Oct 1;6(5):373- 9.
42. Sarubin-Fragakis A. The health professional's guide to popular dietary supplements, [Chicago, IL]: American Dietetic Association.
43. Parikh P, Mani U, Iyer U. Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. Journal of Medicinal Food. 2001 Dec 1;4(4):193-9.
44. Lee EH, Park JE, Choi YJ, Huh KB, Kim WY. A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients. Nutrition Research and Practice. 2008 Dec 1;2(4):295-300.
45. Torres-Duran PV, Ferreira-Hermosillo A, Juarez-Oropeza MA. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report. Lipids in Health and Disease. 2007 Dec;6(1):1-8.
46. Mazokopakis EE, Papadomanolaki MG, Fousteris AA, Kotsiris DA, Lampadakis IM, Ganotakis ES. The hepatoprotective and hypolipidemic effects of Spirulina supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study. Ann Gastroenterol. 2014;27(4):387-94.
47. Serban MC, Sahebkar A, Dragan S, StoichescuHogea G, Ursoniu S, Andrica F, Banach M. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clinical Nutrition. 2016 Aug 1;35(4):842-51.
48. Wongcharoen W, Phrommintikul A. The protective role of curcumin in cardiovascular diseases. International journal of cardiology. 2009 Apr 3;133(2):145-51.
49. Panahi Y, Ahmadi Y, Teymouri M, Johnston TP, Sahebkar A. Curcumin as a potential candidate for treating hyperlipidemia: a review of cellular and metabolic mechanisms. Journal of cellular physiology. 2018 Jan;233(1):141-52.
50. Ganjali S, Sahebkar A, Mahdipour E, Jamialahmadi K, Torabi S, Akhlaghi S, Ferns G, Parizadeh SM, Ghayour-Mobarhan M. Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. The Scientific World Journal. 2014 Feb 11;2014.
51. Panahi Y, Hosseini MS, Khalili N, Naimi E, Simental-Mendía LE, Majeed M, Sahebkar A. Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A posthoc analysis of a randomized controlled trial. Biomedicine & pharmacotherapy. 2016 Aug 1;82:578-82.
52. Panahi Y, Khalili N, Hosseini MS, Abbasinazari M, Sahebkar A. Lipid-modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complementary therapies in medicine. 2014 Oct 1;22(5):851-7.
53. Ganjali S, Blesso CN, Banach M, Pirro M, Majeed M, Sahebkar A. Effects of curcumin on HDL functionality. Pharmacological research. 2017 May 1;119:208-18.
54. Guo N, Chen F, Zhou J, Fang Y, Li H, Luo Y, Zhang Y. Curcumin attenuates rapamycin-induced cell injury of vascular endothelial cells. Journal of cardiovascular pharmacology. 2015 Oct 1;66(4):338- 46.
55. S Karimian M, Pirro M, P Johnston T, Majeed M, Sahebkar A. Curcumin and endothelial function: evidence and mechanisms of protective effects. Current pharmaceutical design. 2017 May 1;23(17):2462-73.
56. Appendino G, Belcaro G, Cornelli U, Luzzi R, Togni S, Dugall M, Cesarone MR, Feragalli B, Ippolito E, Errichi BM, Pellegrini L. Potential role of curcuminphytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminervamedica. 2011 Sep 1;53 (3 Suppl 1):43-9.
57. Karuppagounder V, Arumugam S, Giridharan VV, Sreedhar R, Bose RJ, Vanama J, Palaniyandi SS, Konishi T, Watanabe K, Thandavarayan RA. Tiny molecule, big power: multi-target approach for curcumin in diabetic cardiomyopathy. Nutrition. 2017 Feb 1;34:47-54.
58. Giovannetti PM, Carroll KK, Wolfe BM. Constancy of fasting serum cholesterol of healthy young women upon substitution ofsoy protein isolate for meat and dairy protein in medium and low fat diets. Nutrition Research. 1986 Jun 1;6(6):609-18.
59. Jenkins DJ, Wolever TM, Spiller G, Buckley G, Lam Y, Jenkins AL, Josse RG. Hypocholesterolemic effect of vegetable protein in a hypocaloric diet. Atherosclerosis. 1989 Aug 1;78(2-3):99-107.
60. Bosello O, Cominacini L, Zocca I, Garbin U, Compri R, Davoli A, Brunetti L. Shortand long-term effects of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins of obese subjects. Annals of nutrition and metabolism. 1988;32(4):206-14.
61. Sacks FM, Breslow JL, Wood PG, Kass EH. Lack of an effect of dairy protein (casein) and soy protein on plasma cholesterol of strict vegetarians. An experiment and a critical review. Journal of lipid research. 1983 Aug 1;24(8):1012-20.
62. Wong WW, Smith EO, Stuff JE, Hachey DL, Heird WC, Pownell HJ. Cholesterollowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. The American journal of clinical nutrition. 1998 Dec 1;68(6):1385S-9S.
63. Baum JA, Teng H, Erdman Jr JW, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. The American journal of clinical nutrition. 1998 Sep 1;68(3):545-51.
64. Kurowska EM, Jordon J, Spence JD, Wetmore S. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia. Clinical and investigative medicine. 1997 Jun 1;20(3):162.
65. Fonda G, Pranata R, Deka H. Role of Omega-3 Fatty Acids in Dyslipidemia and Cardiovascular Diseases. Indonesian Journal of Cardiology. 2016:213-2.
66. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology. 2011 Nov 8;58(20):2047-67.
67. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. The Journal of nutritional biochemistry. 2010 Sep 1;21(9):781-92.
68. Toft AD, Thorn M, Ostrowski K, Asp S, Moller K, Iversen S, Hermann C, Søndergaard SR, Pedersen BK. N-3 polyunsaturated fatty acids do not affect cytokine response to strenuous exercise. Journal of applied physiology. 2000 Dec 1;89(6):2401-6.
69. Massaro M, Scoditti E, Carluccio MA, De Caterina R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2008 Sep 1;79(3-5):109-15.
70. Cohen MG, Rossi JS, Garbarino J, Bowling R, Motsinger-Reif AA, Schuler C, Dupont AG, Gabriel D. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel. Thrombosis research. 2011 Oct 1;128(4):335-40.
71. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008 Mar 1;197(1):12-24.
72. Jacobson TA, Glickstein SB, Rowe JD, Soni PN. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. Journal of clinical lipidology. 2012 Jan 1;6(1):5-18.
73. Kromhout D, Giltay EJ, Geleijnse JM. n–3 Fatty acids and cardiovascular events after myocardial infarction. New England Journal of Medicine. 2010 Nov 18;363(21):2015- 26.
74. Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B. Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circulation: Cardiovascular Quality and Outcomes. 2012 Nov;5(6):808-18.
75. Martino A, Goanta E, Magnano R, Bencivenga S, Pezzi L. Diets and heart disease. Myths and reality. J Nutrition Health Food Sci. 2016;4(1):1-0.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.

About this article

Cite this article

Durgesh Ranjan Kar, Subhadip Bera, Abhipsa Sinha, et al./The job of Nutraceuticals in the avoidance of Cardiovascular disease/J Pharmaceut Med Chem. 2023;9(2): 65-72.

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Received	Accepted	Published
September 13, 2023	October 30, 2023	December 25, 2023

DOI: https://doi.org/10.21088/jpmc.2395.6615.9223.3

Keywords

NeutraceuticalCardiovascular disease (CVD)LycopeneCurcumin


Format	India	Outside
Print	₹396	$31
Print+Online	₹396	$31
Online Only	₹375	$29
Ebook	₹375	$29

Journal of Pharmaceutical and Medicinal Chemistry

Journal of Pharmaceutical and Medicinal Chemistry

Review Article

The Job of Nutraceuticals in the Avoidance of Cardiovascular Disease

Authors and Affiliatione

Licence:

How Cite This Article:

Timeline

Abstract

References

Funding

Author Contributions

Ethics Declaration

Acknowledgements

Conflicts of Interest

About this article

Cite this article

Licence:

Keywords

Search for Similar Articles

Similar Articles

Article Level Metrics

Accesses

Citations

Article Keywords

Keyword Highlighting

Timeline

licence

Access this article

Share

Add to Favourites

Journal of Pharmaceutical and Medicinal Chemistry

Review Article

The Job of Nutraceuticals in the Avoidance of Cardiovascular Disease

Authors and Affiliatione

Licence:

How Cite This Article:

Timeline

Abstract

References

Data Sharing Statement

Funding

Author Contributions

Ethics Declaration

Acknowledgements

Conflicts of Interest

About this article

Cite this article

Licence:

Keywords

Search for Similar Articles

Similar Articles

Article Level Metrics

Accesses

Citations

Article Keywords

Keyword Highlighting

Timeline

licence

Access this article

Share

Add to Favourites

To save this item, login or register